We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
AstraZeneca
AZN
$290B
| – | – |
-80,130
| Closed | -$15.8M | – |
|
352
Beam Therapeutics
BEAM
$2.6B
| – | – |
-15,518
| Closed | -$370K | – |
|
353
Belite Bio
BLTE
$6.29B
| – | – |
-33,492
| Closed | -$5.34M | – |
|
354
BioNTech
BNTX
$21.6B
| – | – |
-119,204
| Closed | -$10.6M | – |
|
355
Citigroup
C
$202B
| – | – |
-180,620
| Closed | -$20.5M | – |
|
|
356
Citizens Financial Group
CFG
$27.3B
| – | – |
-785,893
| Closed | -$47.1M | – |
|
357
Centene
CNC
$34.5B
| – | – |
-199,000
| Closed | -$6.52M | – |
|
358
Cogent Biosciences
COGT
$5.56B
| – | – |
-335,000
| Closed | -$12.9M | – |
|
359
Charles River Laboratories
CRL
$16.7B
| – | – |
-36,721
| Closed | -$6.33M | – |
|
360
CytomX Therapeutics
CTMX
$427M
| – | – |
-550,000
| Closed | -$2.58M | – |
|
361
Cognizant
CTSH
$29B
| – | – |
-548,800
| Closed | -$33.7M | – |
|
362
Diodes
DIOD
$3.99B
| – | – |
-94,881
| Closed | -$6.48M | – |
|
363
East-West Bancorp
EWBC
$18B
| – | – |
-36,913
| Closed | -$3.94M | – |
|
364
First Horizon
FHN
$11.1B
| – | – |
-399,537
| Closed | -$9.09M | – |
|
365
Fiserv Inc
FISV
$33.7B
| – | – |
-123,042
| Closed | -$6.87M | – |
|
366
GDS Holdings
GDS
$4.26B
| – | – |
-135,882
| Closed | -$5.47M | – |
|
367
Hubbell
HUBB
$23.2B
| – | – |
-6,371
| Closed | -$3.13M | – |
|
368
IBM
IBM
$231B
| – | – |
-380
| Closed | -$92.1K | – |
|
369
Immatics
IMTX
$970M
| – | – |
-780,967
| Closed | -$7.68M | – |
|
370
Inspire Medical Systems
INSP
$1.8B
| – | – |
-138,761
| Closed | -$7.16M | – |
|
371
JB Hunt Transport Services
JBHT
$21.1B
| – | – |
-5,941
| Closed | -$1.26M | – |
|
372
Jack Henry & Associates
JKHY
$12.2B
| – | – |
-128,056
| Closed | -$20.2M | – |
|
373
KKR & Co
KKR
$90B
| – | – |
-349,327
| Closed | -$32.3M | – |
|
374
Lincoln Electric
LECO
$15.4B
| – | – |
-1,674
| Closed | -$417K | – |
|
375
Lennox International
LII
$11.9B
| – | – |
-496
| Closed | -$230K | – |
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.